Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Thyroid Cancer, Papillary × Iodine-131 × Clear all

Phase

Phase 2 3 Phase 1 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Neoplasms 2 Thyroid Cancer, Papillary 1 Infertility 1 Adenocarcinoma, Follicular 1

Interventions

Radiofrequency Ablation 2 dabrafenib 1 Thyroid (USP) 1 Robotic Surgical Procedures 1 Iodine-131 1 Gefitinib 1 Ferrosoferric Oxide 1 Ethanol 1 Digoxin 1 Conversion to Open Surgery 1 Administration, Cutaneous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04354324 2024-03-15

Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma

Zhujiang Hospital

Phase NA Recruiting

EndocrineHead & Neck

Thyroid Cancer, Papillary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡